CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
Abstract More than 70% of colorectal, prostate, ovarian, pancreatic and breast cancer specimens show expression of CD276 (B7–H3), a potential immune checkpoint family member. Several studies have shown that high CD276 expression in cancer cells correlates with a poor clinical prognosis. This has bee...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3514e95bf4724fdea484cf4f1f37996c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|